annual CFI:
-$36.00M+$112.42M(+75.75%)Summary
- As of today (July 11, 2025), ELVN annual cash flow from investing activities is -$36.00 million, with the most recent change of +$112.42 million (+75.75%) on December 31, 2024.
- During the last 3 years, ELVN annual CFI has fallen by -$35.81 million (-18746.60%).
- ELVN annual CFI is now -18746.60% below its all-time high of -$191.00 thousand, reached on December 31, 2021.
Performance
ELVN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$1.43M+$700.00K(+96.29%)Summary
- As of today (July 11, 2025), ELVN quarterly cash flow from investing activities is $1.43 million, with the most recent change of +$700.00 thousand (+96.29%) on March 31, 2025.
- Over the past year, ELVN quarterly CFI has increased by +$19.31 million (+107.98%).
- ELVN quarterly CFI is now -96.31% below its all-time high of $38.69 million, reached on December 31, 2023.
Performance
ELVN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$16.68M+$19.31M(+53.65%)Summary
- As of today (July 11, 2025), ELVN TTM cash flow from investing activities is -$16.68 million, with the most recent change of +$19.31 million (+53.65%) on March 31, 2025.
- Over the past year, ELVN TTM CFI has increased by +$149.58 million (+89.96%).
- ELVN TTM CFI is now -950.41% below its all-time high of $1.96 million, reached on September 30, 2024.
Performance
ELVN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ELVN Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +75.8% | +108.0% | +90.0% |
| 3 y3 years | -10000.0% | +835.6% | -8500.5% |
| 5 y5 years | -7708.5% | - | - |
ELVN Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | +75.8% | -96.3% | +100.9% | -950.4% | +91.1% |
| 5 y | 5-year | <-9999.0% | +75.8% | -96.3% | +100.9% | -950.4% | +91.1% |
| alltime | all time | <-9999.0% | +75.8% | -96.3% | +100.9% | -950.4% | +91.1% |
ELVN Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.43M(+96.3%) | -$16.68M(-53.6%) |
| Dec 2024 | -$36.00M(-75.7%) | $727.00K(-95.1%) | -$36.00M(-1934.7%) |
| Sep 2024 | - | $14.83M(-144.0%) | $1.96M(-104.1%) |
| Jun 2024 | - | -$33.66M(+88.2%) | -$48.41M(-70.9%) |
| Mar 2024 | - | -$17.89M(-146.2%) | -$166.27M(+12.0%) |
| Dec 2023 | -$148.41M | $38.69M(-208.8%) | -$148.41M(-20.7%) |
| Sep 2023 | - | -$35.55M(-76.5%) | -$187.20M(+23.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$151.52M(>+9900.0%) | -$151.66M(>+9900.0%) |
| Mar 2023 | - | -$31.00K(-69.3%) | -$449.00K(-26.6%) |
| Dec 2022 | -$612.00K(+220.4%) | -$101.00K(+621.4%) | -$612.00K(+19.8%) |
| Sep 2022 | - | -$14.00K(-95.4%) | -$511.00K(+2.8%) |
| Jun 2022 | - | -$303.00K(+56.2%) | -$497.00K(+156.2%) |
| Mar 2022 | - | -$194.00K | -$194.00K |
| Dec 2021 | -$191.00K(-58.6%) | - | - |
| Dec 2020 | -$461.00K | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual CFI year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Enliven Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM CFI year-on-year change?
What is Enliven Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of ELVN is -$36.00M
What is the all time high annual CFI for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual cash flow from investing activities is -$191.00K
What is Enliven Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, ELVN annual cash flow from investing activities has changed by +$112.42M (+75.75%)
What is Enliven Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of ELVN is $1.43M
What is the all time high quarterly CFI for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $38.69M
What is Enliven Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, ELVN quarterly cash flow from investing activities has changed by +$19.31M (+107.98%)
What is Enliven Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of ELVN is -$16.68M
What is the all time high TTM CFI for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM cash flow from investing activities is $1.96M
What is Enliven Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, ELVN TTM cash flow from investing activities has changed by +$149.58M (+89.96%)